Inventor · disambiguated record
Scott Antonia
Also filed as: ANTONIA SCOTT · ANTONIA SCOTT J · ANTONIA SCOTT JOSEPH
8 granted patents·11 pending applications·7 citations·filing 2006–2025
78Inventor score
Files withH LEE MOFFITT CANCER CT & RES14UNIV SOUTH FLORIDA2ANTONIA SCOTT1H LEE MOFFITT CANCER AND RES INSTITUTE INC1H LEE MOFFITT CANCER CT AND RES INSTITUTUTE INC1
Top patents by PatentIndex Score
19 records- 0182US10449227B2Conjugates for immunotherapyH LEE MOFFITT CANCER CT & RES·Filed 2015·Granted Oct 22, 2019·2 cites·9 claims
- 0281US10414810B2Double mutant survivin vaccineH LEE MOFFITT CANCER CT & RES·Filed 2016·Granted Sep 17, 2019·2 cites·10 claims
- 0379US8668905B2P53 vaccines for the treatment of cancersANTONIA SCOTT·Filed 2006·Granted Mar 11, 2014·3 cites·35 claims
- 0473US12344642B2Variant survivin vaccine for treatment of myelomaH LEE MOFFITT CANCER CT & RES·Filed 2021·Granted Jul 1, 2025·0 cites·12 claims
- 0572US11149072B2Variant survivin vaccine for treatment of myelomaH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Oct 19, 2021·0 cites·19 claims
- 0671US2024041972A1Conjugates for immunotherapyH LEE MOFFITT CANCER CT & RES·Filed 2023·Application pending·0 cites
- 0768US2025179132A1Variant survivin vaccine for treatment of cancerH LEE MOFFITT CANCER CT & RES·Filed 2025·Application pending·0 cites
- 0866US2011059137A1Chemokine gene-modified cells for cancer immunotherapyH LEE MOFFITT CANCER CT AND RES INSTITUTUTE INC·Filed 2009·Application pending·0 cites
- 0960US2015044240A1P53 vaccines for the treatment of cancersUNIV SOUTH FLORIDA·Filed 2014·Application pending·0 cites
- 1059US2021253707A1Gm-csf/cd40l vaccine and checkpoint inhibitor combination therapyH LEE MOFFITT CANCER AND RES INSTITUTE INC·Filed 2021·Application pending·0 cites
- 1158US2020188472A1Conjugates for immunotherapyH LEE MOFFITT CANCER CT & RES·Filed 2019·Application pending·0 cites
- 1257US2013251752A1Chemokine gene-modified cells for cancer immunotherapyUNIV SOUTH FLORIDA·Filed 2013·Application pending·0 cites
- 1356US10995140B2GM-CSF/CD40L vaccine and checkpoint inhibitor combination therapyH LEE MOFFITT CANCER CT & RES·Filed 2016·Granted May 4, 2021·0 cites·4 claims
- 1451US11071775B2Combination immunotherapy for treating cancerH LEE MOFFITT CANCER CT & RES·Filed 2016·Granted Jul 27, 2021·0 cites·22 claims
- 1551US2023235008A1Novel t cell receptors (tcrs) that react to neoantigensH LEE MOFFITT CANCER CT & RES·Filed 2021·Application pending·0 cites
- 1651US2015044224A1Materials and methods for differential treatment of cancerH LEE MOFFITT CANCER CT & RES·Filed 2013·Application pending·0 cites
- 1751US2017121776A1Materials and methods for differential treatment of cancerH LEE MOFFITT CANCER CT & RES·Filed 2016·Application pending·0 cites
- 1850US12239666B2Oncolytic virus or antigen presenting cell mediated cancer therapy using type I interferon and CD40-ligandH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Mar 4, 2025·0 cites·8 claims
- 1948US2022257735A1A peptide-based screening method to identify neoantigens for use with tumor infiltrating lymphocytesH LEE MOFFITT CANCER CT & RES·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →